Literature DB >> 16801031

Hematological and biochemical factors predicting SARS fatality in Taiwan.

Hsiao-Ling Chang1, Kow-Tong Chen, Shu-Kuan Lai, Hung-Wei Kuo, Ih-Jen Su, Ruey S Lin, Fung-Chang Sung.   

Abstract

BACKGROUND/
PURPOSE: Severe acute respiratory syndrome (SARS) has a high fatality rate worldwide. We examined the epidemiologic and clinical factors associated with death for all laboratory-confirmed SARS patients in Taiwan.
METHODS: Using initial data in medical records reported by hospitals to the Center for Disease Control in Taiwan, we analyzed whether hematological, biochemical and arterial blood gas measures could predict fatality in 346 SARS patients.
RESULTS: Both fatalities (n = 73; 21.1%) and survivors had elevated plasma concentration of initial C-reactive protein (CRP), but the mean CRP concentration was higher in fatalities (47.7 +/- 43.3 mg/L) than in survivors (24.6 +/- 28.2 mg/L). Initial lymphocyte counts were low in both fatalities (814 +/- 378/microL) and survivors (1019 +/- 480/microL). After controlling for age and sex, multiple logistic regression analysis showed that hematological factors significantly associated with fatality included initial neutrophil count > 7000/microL (odds ratio [OR] = 6.4), initial CRP concentration > 47.5 mg/L (OR = 5.8) and lactic acid dehydrogenase (LDH) > 593.5 IU/L (OR = 4.2). Factors significantly associated with initial CRP concentration > 47.5 mg/L included dyspnea (OR = 4.3), red blood cell count < 4.1 x 106/microL (OR = 4.3) and serum aspartate aminotransferase > 57 IU/L (OR = 3.1).
CONCLUSION: Initial neutrophil count, CRP and LDH levels are important predictors of mortality from SARS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801031      PMCID: PMC7135597          DOI: 10.1016/S0929-6646(09)60183-2

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  35 in total

Review 1.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

2.  Serum C-reactive protein levels in disease.

Authors:  J J Morley; I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

3.  Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report.

Authors:  Moira Chan-Yeung; W C Yu
Journal:  BMJ       Date:  2003-04-19

4.  Adenoviral diseases in children: a study of 105 hospital cases.

Authors:  O Ruuskanen; O Meurman; H Sarkkinen
Journal:  Pediatrics       Date:  1985-07       Impact factor: 7.124

5.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Authors:  Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita R Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara D Mederski; Steven B Shadowitz; Wayne L Gold; Laura A Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Journal:  JAMA       Date:  2003-05-06       Impact factor: 56.272

6.  Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

Authors:  A Antinori; G Maiuro; F Pallavicini; F Valente; G Ventura; G Marasca; R Murri; E Pizzigallo; G Camilli; E Tamburrini
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

7.  C-reactive protein and the risk of developing hypertension.

Authors:  Howard D Sesso; Julie E Buring; Nader Rifai; Gavin J Blake; J Michael Gaziano; Paul M Ridker
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

8.  Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality.

Authors:  Owen Tak-Yin Tsang; Tai-Nin Chau; Kin-Wing Choi; Eugene Yuk-Keung Tso; Wilina Lim; Ming-Chi Chiu; Wing-Lok Tong; Po-Oi Lee; Bosco Hoi Shiu Lam; Tak-Keung Ng; Jak-Yiu Lai; Wai-Cho Yu; Sik-To Lai
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

9.  Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients.

Authors:  Jann-Tay Wang; Wang-Huei Sheng; Chi-Tai Fang; Yee-Chun Chen; Jiun-Ling Wang; Chong-Jen Yu; Shan-Chwen Chang; Pan-Chyr Yang
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

10.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.

Authors:  Christl A Donnelly; Azra C Ghani; Gabriel M Leung; Anthony J Hedley; Christophe Fraser; Steven Riley; Laith J Abu-Raddad; Lai-Ming Ho; Thuan-Quoc Thach; Patsy Chau; King-Pan Chan; Tai-Hing Lam; Lai-Yin Tse; Thomas Tsang; Shao-Haei Liu; James H B Kong; Edith M C Lau; Neil M Ferguson; Roy M Anderson
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

View more
  23 in total

1.  C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection.

Authors:  Ofer Zimmerman; Ori Rogowski; Galit Aviram; Michal Mizrahi; David Zeltser; Dan Justo; Esther Dahan; Roy Arad; Oholi Touvia; Luba Tau; Jalal Tarabeia; Shlomo Berliner; Yael Paran
Journal:  BMC Infect Dis       Date:  2010-10-04       Impact factor: 3.090

2.  Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study.

Authors:  Xinkui Liu; Xinpei Yue; Furong Liu; Le Wei; Yuntian Chu; Honghong Bao; Yichao Dong; Wenjie Cheng; Linpeng Yang
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

3.  Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.

Authors:  Mohammad Parohan; Sajad Yaghoubi; Asal Seraji
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2020-06-21

4.  Association of ICAM3 genetic variant with severe acute respiratory syndrome.

Authors:  Kelvin Y K Chan; Johannes C Y Ching; M S Xu; Annie N Y Cheung; Shea-Ping Yip; Loretta Y C Yam; Sik-To Lai; Chung-Ming Chu; Andrew T Y Wong; You-Qiang Song; Fang-Ping Huang; Wei Liu; P H Chung; G M Leung; Eudora Y D Chow; Eric Y T Chan; Jane C K Chan; Hextan Y S Ngan; Paul Tam; Li-Chong Chan; Pak Sham; Vera S F Chan; Malik Peiris; Steve C L Lin; Ui-Soon Khoo
Journal:  J Infect Dis       Date:  2007-06-05       Impact factor: 5.226

5.  COVID-19 and liver dysfunction: A systematic review and meta-analysis of retrospective studies.

Authors:  Mohanad Youssef; Mohammad H Hussein; Abdallah S Attia; Rami M Elshazli; Mahmoud Omar; Ghassan Zora; Ashraf S Farhoud; Ahmad Elnahla; Areej Shihabi; Eman A Toraih; Manal S Fawzy; Emad Kandil
Journal:  J Med Virol       Date:  2020-07-27       Impact factor: 20.693

6.  Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).

Authors:  Yan Yufei; Liu Mingli; Li Xuejiao; Deng Xuemei; Jin Yiming; Qin Qin; Shen Hui; Guo Jie
Journal:  Scand J Clin Lab Invest       Date:  2020-08-17       Impact factor: 1.713

Review 7.  Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm?

Authors:  Carlos Antunes Brito; Fabio Marinho Barros; Edmundo Pessoa Lopes
Journal:  World J Hepatol       Date:  2020-08-27

Review 8.  Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies.

Authors:  Mohammad Parohan; Sajad Yaghoubi; Asal Seraji
Journal:  Hepatol Res       Date:  2020-06-25       Impact factor: 4.942

Review 9.  Liver injury during highly pathogenic human coronavirus infections.

Authors:  Ling Xu; Jia Liu; Mengji Lu; Dongliang Yang; Xin Zheng
Journal:  Liver Int       Date:  2020-03-30       Impact factor: 8.754

10.  Case fatality of SARS in mainland China and associated risk factors.

Authors:  Na Jia; Dan Feng; Li-Qun Fang; Jan Hendrik Richardus; Xiao-Na Han; Wu-Chun Cao; Sake J de Vlas
Journal:  Trop Med Int Health       Date:  2009-04-17       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.